Dodgy data misleads policymakers, businesses and investors
Restaurant and deli owner wants landlord Shaftesbury Capital to reduce cost of leases
Britain’s largest force plans for major cuts to staff and services if budget negotiations fail
This is a time for treating people as individuals rather than as members of a tribe
Delay from planned spring 2025 Treasury announcement will extend period of uncertainty for government departments
Jay Bhattacharya at the NIH would be the latest ally of Robert F Kennedy Jr to take a role overseeing US healthcare
New York Times has sued European Commission over its refusal to release president’s exchanges with Pfizer chief
Abbott Laboratories’ ‘virus hunters’ are tracking disease risks exacerbated by climate change
It is too early to know whether the prompt response to the virus is enough to turn the tide
Also in this newsletter: How greener corporate car fleets could boost competitiveness and the climate goals
Official report raises questions about cost to taxpayer of pandemic schemes
Swiss pharma group is a high spender on R&D but has had misses in Alzheimer’s and cancer
Economy expanded 0.5% in second quarter compared with initial estimate of 0.6%
Emmanuel Hanon criticises former company’s drug after he raises $100mn for rival product
More aggressive actions and better co-ordinated responses needed to contain viruses, say public health experts
Flying blind is dangerous. Technology can build on the basics of local and national data collection
Issue hampers effort to exploit mRNA technology’s promise in tackling deadly viral outbreaks
Early warning system requires roll out of latest testing techniques, Covid levels of co-operation and greater regulatory harmonisation
European Court of Auditors says closer co-operation on data and testing would help fix shortcomings exposed by Covid
Also in this newsletter: Can Brussels block mergers outside of the EU?
Wealthy world must help Africa prevent a potential regional health catastrophe
Chief of Facebook parent says Biden administration was ‘wrong’ and is ready to ‘push back’ in future
Jab makers fall behind Moderna in post-pandemic market with disappointing results
Wild birds are more likely to be carriers of antibiotic-resistant bacteria if they live close to humans, says study
A surge in infections will boost companies’ shares but this sector’s volatility makes them a poor long-term bet
